South Korea’s SK Bioscience Co. is looking to post 1 trillion won ($900 million) in annual revenue from its vaccine business as the biopharmace...

Samsung Biologics Co. delivered forecast-beating earnings this week, with its sales topping 1 trillion won ($905 million) for the first time in its n...

South Korea is emerging as a global hub for the contract manufacturing of biopharmaceuticals following its latest deal to procure COVID-19 vaccines f...

South Korea's Celltrion Inc. has completed second-phase clinical trials of its COVID-19 treatment and is seeking conditional approval of its distrib...

It's a busy day at the Korea Superfreeze warehouse in South Korea's Gyeonggi province, with trucks entering and exiting the spacious 92,500-square-m...

South Korea’s biopharmaceutical firm Celltrion Inc. can unveil an antibody treatment by around the end of the year that is able to kill the COVI...